A-40174
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C26H37NO2 |
Molar mass | 395.587 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
A-40174 (SP-1) is an analgesic drug which acts as a potent cannabinoid receptor agonist, and was developed by Abbott Laboratories in the 1970s.[1] It is a structural analog of dronabinol and dimethylheptylpyran.
See also
References
- ^ Razdan RK (2009). "Structure–Activity Relationships of Classical Cannabinoids". In Reggio PR (ed.). The Cannabinoid Receptors. The Receptors. pp. 3–19. doi:10.1007/978-1-59745-503-9_1. ISBN 978-1-58829-712-9.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.